William D. Waddill - 15 Dec 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/William Waddill
Issuer symbol
ARWR
Transactions as of
15 Dec 2023
Net transactions value
+$380,820
Form type
4
Filing time
19 Dec 2023, 15:41:34 UTC
Previous filing
12 Jun 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $380,820 +14,987 +41% $25.41 51,804 15 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying restricted stock units, which will vest in one installment on the first anniversary date.